Dijie Liu

658 total citations
27 papers, 499 citations indexed

About

Dijie Liu is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Dijie Liu has authored 27 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Dijie Liu's work include Radiopharmaceutical Chemistry and Applications (17 papers), Medical Imaging Techniques and Applications (7 papers) and Medical Imaging and Pathology Studies (6 papers). Dijie Liu is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (17 papers), Medical Imaging Techniques and Applications (7 papers) and Medical Imaging and Pathology Studies (6 papers). Dijie Liu collaborates with scholars based in United States and South Korea. Dijie Liu's co-authors include Kevin G. Rice, Ji‐Seon Kim, Garrett R. Rettig, Michael R. Lewis, Chang-Po Chen, Frances L. Johnson, Hyun‐Soon Chong, Mengshi Li, Erin R. Steenblock and Michael K. Schultz and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Molecular Therapy.

In The Last Decade

Dijie Liu

27 papers receiving 488 citations

Peers

Countries citing papers authored by Dijie Liu

Since Specialization

Citations

This map shows the geographic impact of Dijie Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dijie Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dijie Liu more than expected).

Fields of papers citing papers by Dijie Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dijie Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dijie Liu. The network helps show where Dijie Liu may publish in the future.

Co-authorship network of co-authors of Dijie Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Dijie Liu. A scholar is included among the top collaborators of Dijie Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dijie Liu. Dijie Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth 2024 ·Cancer Biology & Therapy ·(unknown), Dijie Liu, (unknown), (unknown), Casey Pulliam, (unknown), (unknown), Brian Wels, Shane R. Solst, M. Sue O’Dorisio, Yusuf Menda, Douglas R. Spitz, Melissa A. Fath	6
2	Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for 203Pb and 212Pb-Based Theranostics 2023 ·Pharmaceutics ·Mengshi Li, Nicholas J. Baumhover, Dijie Liu, (unknown), Fréderic Boschetti, (unknown), (unknown), Cong Dai, (unknown), (unknown), (unknown), (unknown), Moustafa T. Gabr, F. Christopher Pigge, Frances L. Johnson, Michael K. Schultz	29
3	Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Mengshi Li, Dijie Liu, Nicholas J. Baumhover, (unknown), (unknown), Prerna Rastogi, F. Christopher Pigge, Yusuf Menda, Frances L. Johnson, Michael K. Schultz	14
4	Abstract 5034: Targeting CXCR4 and thioredoxin reductase in high grade neuroendocrine tumors and neuroendocrine carcinomas 2023 ·Cancer Research ·Melissa A. Fath, Dijie Liu, (unknown), (unknown), (unknown), (unknown), Stephen A. Graves, Douglas R. Spitz, Yusuf Menda, M. Sue O’Dorisio	1
5	Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Mengshi Li, (unknown), Dijie Liu, Stephen A. Graves, (unknown), (unknown), (unknown), Prerna Rastogi, (unknown), (unknown), Robert M. Weiss, (unknown), Frances L. Johnson, Michael K. Schultz, Diana Zepeda‐Orozco	3
6	Synthesis and evaluation of Diaza-Crown Ether-Backboned chelator containing hydroxamate groups for Zr-89 chelation chemistry 2022 ·Bioorganic & Medicinal Chemistry Letters ·Shuyuan Zhang, Hai Wang, Siyuan Ren, (unknown), Dijie Liu, Mengshi Li, (unknown), Hyun‐Soon Chong	5
7	Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma 2021 ·Cancers ·Mengshi Li, Dijie Liu, (unknown), (unknown), Nicholas J. Baumhover, (unknown), (unknown), Zuhair K. Ballas, Frances L. Johnson, Zachary S. Morris, Michael K. Schultz	37
8	New Bifunctional Chelator 3p-C-NEPA for Potential Applications in Lu(III) and Y(III) Radionuclide Therapy and Imaging 2020 ·ACS Omega ·Xiang Sun, Chi Soo Kang, (unknown), Shuyuan Zhang, Siyuan Ren, Hai Wang, Dijie Liu, Michael R. Lewis, Hyun‐Soon Chong	2
9	Automated cassette-based production of high specific activity [203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer 2017 ·Applied Radiation and Isotopes ·Mengshi Li, Xiuli Zhang, Thomas P. Quinn, (unknown), Dijie Liu, (unknown), Brian E. Zimmerman, Daniel R. McAlister, (unknown), Yusuf Menda, Saed Mirzadeh, Roy Copping, Frances L. Johnson, Michael K. Schultz	36
10	Targeted antisense radiotherapy and dose fractionation using a 177Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate 2015 ·Nuclear Medicine and Biology ·Dijie Liu, (unknown), Fang Jia, (unknown), Charles J. Smith, Michael R. Lewis	2
11	Promising bifunctional chelators for copper 64-PET imaging: practical 64Cu radiolabeling and high in vitro and in vivo complex stability 2015 ·JBIC Journal of Biological Inorganic Chemistry ·Ningjie Wu, Chi Soo Kang, (unknown), Siyuan Ren, Dijie Liu, (unknown), Michael R. Lewis, Hyun‐Soon Chong	35
12	Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation 2015 ·Journal of Inorganic Biochemistry ·Chi Soo Kang, Ningjie Wu, Yunwei Chen, Xiang Sun, Nilantha Bandara, Dijie Liu, Michael R. Lewis, Buck E. Rogers, Hyun‐Soon Chong	4
13	Synthesis and comparative biological evaluation of bifunctional ligands for radiotherapy applications of 90Y and 177Lu 2014 ·Bioorganic & Medicinal Chemistry ·Hyun‐Soon Chong, Xiang Sun, Yunwei Chen, (unknown), Chi Soo Kang, Michael R. Lewis, Dijie Liu, (unknown), (unknown), Ningjie Wu, Hyun A. Song	20
14	Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using90Y or177Lu 2014 ·Nuclear Medicine and Biology ·Chi Soo Kang, Yunwei Chen, Hyunbeom Lee, Dijie Liu, Xiang Sun, Junghun Kweon, Michael R. Lewis, Hyun‐Soon Chong	27
15	Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy 2014 ·Nuclear Medicine and Biology ·(unknown), (unknown), Dijie Liu, Jingli Xu, Yubin Miao, Timothy J. Hoffman, Tammy L. Rold, Michael R. Lewis, Charles J. Smith	27
16	Comparative biodistributions and dosimetry of [177Lu]DOTA-anti-bcl-2-PNA-Tyr3-octreotate and [177Lu]DOTA-Tyr3-octreotate in a mouse model of B-cell lymphoma/leukemia 2013 ·Nuclear Medicine and Biology ·(unknown), Dijie Liu, Fang Jia, (unknown), (unknown), William H. Miller, Michael R. Lewis	12
17	In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone. 2009 ·PubMed ·Dijie Liu, Douglas M. Overbey, Lisa Watkinson, (unknown), Timothy J. Hoffman, Leonard R. Forte, Wynn A. Volkert, Michael F. Giblin	16
18	Synthesis and Characterization of an¹¹¹In-Labeled Peptide for the in Vivo Localization of Human Cancers Expressing the Urokinase-Type Plasminogen Activator Receptor (uPAR) 2009 ·Bioconjugate Chemistry ·Dijie Liu, Douglas M. Overbey, Lisa Watkinson, Michael F. Giblin	19
19	Quantitative bioluminescence imaging of transgene expression in vivo 2006 ·Analytical Biochemistry ·Garrett R. Rettig, (unknown), Dijie Liu, (unknown), Kevin G. Rice	48
20	401. Quantitative Bioluminescence Imaging of Transgene Expression In Vivo 2006 ·Molecular Therapy ·Garrett R. Rettig, (unknown), Dijie Liu, (unknown), Kevin G. Rice	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact